IDEAYA Biosciences (IDYA) Net Cash Flow (QoQ) (2018 - 2026)
IDEAYA Biosciences (IDYA) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | IDEAYA Biosciences | 3.21 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.19% |
| Dec 31, 2025 | -200.87% |
| Sep 30, 2025 | 1,300.46% |
| Jun 30, 2025 | -133.65% |
| Mar 31, 2025 | 114.44% |
| Dec 31, 2024 | -245.47% |
| Sep 30, 2024 | 190.19% |
| Jun 30, 2024 | 253.80% |
| Mar 31, 2024 | -1,035.48% |
| Dec 31, 2023 | -89.38% |
| Sep 30, 2023 | 35.30% |
| Jun 30, 2023 | 2,696.56% |
| Mar 31, 2023 | 95.81% |
| Dec 31, 2022 | -163.05% |
| Sep 30, 2022 | 954.45% |
| Jun 30, 2022 | 83.17% |
| Mar 31, 2022 | -124.36% |
| Dec 31, 2021 | -191.01% |
| Sep 30, 2021 | 138.86% |
| Jun 30, 2021 | -171.58% |